It is currently 19 Nov 2017, 07:28

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Close

Request Expert Reply

Confirm Cancel

Events & Promotions

Events & Promotions in June
Open Detailed Calendar

The introduction of new drugs into the market is frequently

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:

Hide Tags

2 KUDOS received
Senior Manager
Senior Manager
User avatar
Status: Always try to face your worst fear because nothing GOOD comes easy. You must be UNCOMFORTABLE to get to your COMFORT ZONE
Joined: 15 Aug 2014
Posts: 354

Kudos [?]: 91 [2], given: 472

Concentration: Marketing, Technology
GMAT 1: 570 Q44 V25
GMAT 2: 600 Q48 V25
WE: Information Technology (Consulting)
GMAT ToolKit User Reviews Badge
The introduction of new drugs into the market is frequently [#permalink]

Show Tags

New post 15 Jun 2016, 09:30
2
This post received
KUDOS
30
This post was
BOOKMARKED
00:00
A
B
C
D
E

Difficulty:

  75% (hard)

Question Stats:

61% (01:37) correct 39% (02:04) wrong based on 1276 sessions

HideShow timer Statistics

The introduction of new drugs into the market is frequently prevented by a shortage of human subjects for the clinical trials
needed to show that the drugs are safe and effective. Since the lives and health of people in future generations may depend
on treatments that are currently experimental, practicing physicians are morally in the wrong when, in the absence of any
treatment proven to be effective, they fail to encourage suitable patients to volunteer for clinical trials.

Which of the following, if true, casts most doubt on the conclusion of the argument?

A) Many drugs undergoing clinical trials ate intended for the treatment of conditions for which there is currently no effective treatment.
B) Patients do not share the physician’s professional concern for public health, but everyone has a moral obligation to alleviate suffering
when able to do so.
C) Usually, half the patients in a clinical trial serve as a control group and receive a nonactive drug in place of the drug being tested.
D) An experimental drug cannot legally be made available to patients unless those patients are subjects in clinical trials of the drug.
E) Physicians have an overriding moral and legal duty to care for the health and safety of their current patients.
[Reveal] Spoiler: OA

_________________

"When you want to succeed as bad as you want to breathe, then you’ll be successful.” - Eric Thomas

I need to work on timing badly!!


Last edited by sairam595 on 15 Jun 2016, 22:55, edited 1 time in total.

Kudos [?]: 91 [2], given: 472

SC Moderator
User avatar
P
Joined: 13 Apr 2015
Posts: 1505

Kudos [?]: 1172 [0], given: 890

Location: India
Concentration: Strategy, General Management
WE: Information Technology (Consulting)
GMAT ToolKit User Premium Member CAT Tests
Re: The introduction of new drugs into the market is frequently [#permalink]

Show Tags

New post 15 Jun 2016, 10:31
Argument: In order to find a cure for future generations patients who belong to the current generation must be subjected to experimentation. Since Physicians do not do this, they are morally wrong.

But, if Physicians have an interest to protect the patients who belong to the current generation against experimental trials, they are not morally wrong.

Answer: E

Kudos [?]: 1172 [0], given: 890

Current Student
User avatar
Joined: 18 Oct 2014
Posts: 903

Kudos [?]: 433 [0], given: 69

Location: United States
GMAT 1: 660 Q49 V31
GPA: 3.98
GMAT ToolKit User
Re: The introduction of new drugs into the market is frequently [#permalink]

Show Tags

New post 15 Jun 2016, 14:02
smartguy595 wrote:
The introduction of the new drugs into the market is frequently prevented by a shortage of human subjects for the clinical trials
needed to show that the drugs are safe and effective. Since the lives and health of people in future generations may depend
on treatments that are currently experimental, practicing physicians are morally in the wrong when, in the absence of any
treatment proven to be effective, they fail to encourage suitable patients to volunteer for clinical trials.

Which of the following, if true, casts most doubt on the conclusion of the argument?

A) Many drugs undergoing clinical trials ate intended for the treatment of conditions for which there is currently no effective treatment.
B) Patients do not share the physician’s professional concern for public health, but everyone has a moral obligation to alleviate suffering
when able to do so.
C) Usually, half the patients in a clinical trial serve as a control group and receive a nonactive drug in place of the drug being tested.
D) An experimental drug cannot legally be made available to patients unless those patients are subjects in clinical trials of the drug.
E) Physicians have an overriding moral and legal duty to care for the health and safety of their current patients.

OA will be revealed after few discussions :)


IMO, it is C.

The conclusion says that in the absence of any effective treatment, if a doctor is unable to encourage the patient to volunteer for clinical trial, the doctor is morally wrong.

And the clinical trials might will give a safe and effective treatment.

So, the assumption is that either doctor stays morally wrong or convince the patient for clinical experiment and provide safe and effective treatment.

Option 'C' does not guarantee that the patient will be given safe and effective treatment or will be a part of nonactive drug group. So, it weakens the conclusion that even after convincing the patient to be part of experiment, a doctor might or not be able to provide the treatment and be morally right.

The reason I did not choose E is that although it is moral duty of a doctors to take care of health and safety, it does not mean that they are doing their moral duty.
_________________

I welcome critical analysis of my post!! That will help me reach 700+

Kudos [?]: 433 [0], given: 69

Intern
Intern
avatar
Joined: 03 Jun 2015
Posts: 2

Kudos [?]: [0], given: 7

Location: Australia
Concentration: Social Entrepreneurship, Strategy
GMAT 1: 770 Q51 V44
GPA: 3.5
Re: The introduction of new drugs into the market is frequently [#permalink]

Show Tags

New post 15 Jun 2016, 18:30
As the physicians go by the overriding moral standard expected of them,they cannot be morally wrong. E

Kudos [?]: [0], given: 7

Manager
Manager
avatar
B
Joined: 12 Jan 2016
Posts: 72

Kudos [?]: 24 [0], given: 71

Location: United States
Concentration: Operations, General Management
GMAT 1: 690 Q49 V35
GPA: 3.5
WE: Supply Chain Management (Consumer Electronics)
Re: The introduction of new drugs into the market is frequently [#permalink]

Show Tags

New post 15 Jun 2016, 21:38
The author concludes that physicians are morally in the wrong because they do not help the future generations by failing to encourage their current patients to go to clinical trials. The author assumes that Physicians have a higher moral obligation to protect the lives and health of future generations over current patients.

E) Physicians have an overriding moral and legal duty to care for the health and safety of their current patients.

E clearly states that Physicians have a moral duty to protect the lives and health of their current patients, which clearly flies in the face of the author's assumption and hence weakens the conclusion.

My answer is E.

Kudos [?]: 24 [0], given: 71

Senior Manager
Senior Manager
User avatar
Status: Always try to face your worst fear because nothing GOOD comes easy. You must be UNCOMFORTABLE to get to your COMFORT ZONE
Joined: 15 Aug 2014
Posts: 354

Kudos [?]: 91 [0], given: 472

Concentration: Marketing, Technology
GMAT 1: 570 Q44 V25
GMAT 2: 600 Q48 V25
WE: Information Technology (Consulting)
GMAT ToolKit User Reviews Badge
Re: The introduction of new drugs into the market is frequently [#permalink]

Show Tags

New post 15 Jun 2016, 23:01
Thanks for all the discussions..OA is E

can someone explain why B is incorrect! i fell for B :(
_________________

"When you want to succeed as bad as you want to breathe, then you’ll be successful.” - Eric Thomas

I need to work on timing badly!!

Kudos [?]: 91 [0], given: 472

1 KUDOS received
Intern
Intern
avatar
Joined: 15 Jun 2016
Posts: 1

Kudos [?]: 1 [1], given: 0

Re: The introduction of new drugs into the market is frequently [#permalink]

Show Tags

New post 15 Jun 2016, 23:35
1
This post received
KUDOS
It isn't B, because B is too general. The conclusion states the physicians are morally in the wrong if they don't convince their patients to join clinical trials. This is more muddled and brings up everyone.

Kudos [?]: 1 [1], given: 0

4 KUDOS received
Director
Director
User avatar
Joined: 04 Jun 2016
Posts: 647

Kudos [?]: 377 [4], given: 36

GMAT 1: 750 Q49 V43
The introduction of new drugs into the market is frequently [#permalink]

Show Tags

New post 30 Jul 2016, 09:58
4
This post received
KUDOS
3
This post was
BOOKMARKED
sairam595 wrote:
The introduction of new drugs into the market is frequently prevented by a shortage of human subjects for the clinical trials
needed to show that the drugs are safe and effective. Since the lives and health of people in future generations may depend
on treatments that are currently experimental, practicing physicians are morally in the wrong when, in the absence of any
treatment proven to be effective, they fail to encourage suitable patients to volunteer for clinical trials.

Which of the following, if true, casts most doubt on the conclusion of the argument?

A) Many drugs undergoing clinical trials ate intended for the treatment of conditions for which there is currently no effective treatment.
B) Patients do not share the physician’s professional concern for public health, but everyone has a moral obligation to alleviate suffering
when able to do so.
C) Usually, half the patients in a clinical trial serve as a control group and receive a nonactive drug in place of the drug being tested.
D) An experimental drug cannot legally be made available to patients unless those patients are subjects in clinical trials of the drug.
E) Physicians have an overriding moral and legal duty to care for the health and safety of their current patients.


Answer is E
CONCLUSION IS :--> Since lives of FUTURE PATIENTS depends on clinical trials therefore doctors are morally wrong, when they don't encourage their CURRENT PATIENTS to volunteer for clinical trials.

A Weakener that cast doubt on the CONCLUSION will be :- It's morally right for doctors to care about current patient. and doctors have no obligations towards FUTURE PATIENTS.

What if the clinical trials are dangerous for the current patient and can damage their recovery and health.
Then the doctor can say- Screw the hypothetical future patients. I have to look after my real current patients.


E) Physicians have an overriding moral and legal duty to care for the health and safety of their current patients.

Now if a doctor is morally right he cannot be morally wrong.

This E is the correct weakener.

_________________

Posting an answer without an explanation is "GOD COMPLEX". The world doesn't need any more gods. Please explain you answers properly.
FINAL GOODBYE :- 17th SEPTEMBER 2016. .. 16 March 2017 - I am back but for all purposes please consider me semi-retired.


Last edited by LogicGuru1 on 26 Apr 2017, 06:13, edited 1 time in total.

Kudos [?]: 377 [4], given: 36

Manager
Manager
avatar
B
Joined: 18 Sep 2015
Posts: 109

Kudos [?]: 35 [0], given: 612

GMAT 1: 610 Q43 V31
GMAT 2: 610 Q47 V27
GMAT 3: 650 Q48 V31
GMAT 4: 700 Q49 V35
WE: Project Management (Health Care)
GMAT ToolKit User
Re: The introduction of new drugs into the market is frequently [#permalink]

Show Tags

New post 21 Oct 2016, 07:07
sairam595 wrote:
The introduction of new drugs into the market is frequently prevented by a shortage of human subjects for the clinical trials
needed to show that the drugs are safe and effective. Since the lives and health of people in future generations may depend
on treatments that are currently experimental, practicing physicians are morally in the wrong when, in the absence of any
treatment proven to be effective, they fail to encourage suitable patients to volunteer for clinical trials.

Which of the following, if true, casts most doubt on the conclusion of the argument?

A) Many drugs undergoing clinical trials ate intended for the treatment of conditions for which there is currently no effective treatment.
B) Patients do not share the physician’s professional concern for public health, but everyone has a moral obligation to alleviate suffering
when able to do so.
C) Usually, half the patients in a clinical trial serve as a control group and receive a nonactive drug in place of the drug being tested.
D) An experimental drug cannot legally be made available to patients unless those patients are subjects in clinical trials of the drug.
E) Physicians have an overriding moral and legal duty to care for the health and safety of their current patients.


Logical chain: people for experiment -> experiment -> safe & effective -> drugs are interduced.
Claim: No effective treatment + no candidates for experiments -> Dr. need to convice patients

the conclusion deals with "effective treatment" but not with a safe treatment (this is the logical gap).

E - if the care of patients is most important ("overriding"), then not given drugns that have not been proving as safe is moraliy right. hence this answer weakens the conclusion.

Kudos [?]: 35 [0], given: 612

Manager
Manager
avatar
B
Joined: 23 Apr 2014
Posts: 67

Kudos [?]: 7 [0], given: 82

Location: United States
GMAT 1: 680 Q50 V31
GPA: 2.75
Reviews Badge
Re: The introduction of new drugs into the market is frequently [#permalink]

Show Tags

New post 07 Dec 2016, 14:46
sairam595 wrote:
Thanks for all the discussions..OA is E

can someone explain why B is incorrect! i fell for B :(


The introduction of new drugs into the market is frequently prevented by a shortage of human subjects for the clinical trials
needed to show that the drugs are safe and effective. Since the lives and health of people in future generations may depend
on treatments that are currently experimental, practicing physicians are morally in the wrong when, in the absence of any
treatment proven to be effective, they fail to encourage suitable patients to volunteer for clinical trials.

Which of the following, if true, casts most doubt on the conclusion of the argument?

A) Many drugs undergoing clinical trials ate intended for the treatment of conditions for which there is currently no effective treatment.
B) Patients do not share the physician’s professional concern for public health, but everyone has a moral obligation to alleviate suffering
when able to do so.
C) Usually, half the patients in a clinical trial serve as a control group and receive a nonactive drug in place of the drug being tested.
D) An experimental drug cannot legally be made available to patients unless those patients are subjects in clinical trials of the drug.
E) Physicians have an overriding moral and legal duty to care for the health and safety of their current patients.

Conclusion - Physicians are wrong when they are not able to encourage people to take part in clinical trials.
Option B doesn't talk about physicians but gives a general statement and somewhat means that patients (although they are not supposed to be as concerned as doctors) also have some moral obligation just as doctors have. This statement doesn't do anything to our conclusion. We need something about doctors to confirm that doctors are not wrong if they are not able to encourage patients.
Option E exactly does that as it says that doctors also have duty to care for safety of their current patients, then how can they be wrong if they don't encourage their patients to take part in trials.

Hope this helps.

Kudos [?]: 7 [0], given: 82

Manager
Manager
avatar
Joined: 01 Sep 2016
Posts: 118

Kudos [?]: 10 [0], given: 89

Re: The introduction of new drugs into the market is frequently [#permalink]

Show Tags

New post 25 Dec 2016, 08:18
Thank you for the explanation... 8-)

Vyshak wrote:
Argument: In order to find a cure for future generations patients who belong to the current generation must be subjected to experimentation. Since Physicians do not do this, they are morally wrong.

But, if Physicians have an interest to protect the patients who belong to the current generation against experimental trials, they are not morally wrong.

Answer: E

Kudos [?]: 10 [0], given: 89

Intern
Intern
avatar
B
Joined: 21 Aug 2017
Posts: 11

Kudos [?]: 1 [0], given: 13

GMAT 1: 550 Q34 V31
GMAT 2: 560 Q36 V31
GMAT 3: 660 Q47 V34
Re: The introduction of new drugs into the market is frequently [#permalink]

Show Tags

New post 08 Oct 2017, 10:44
When I personalized this argument, the answer jumped off the page. If you were a doctor with a strong moral code, why would you not recommend patients participate in these trials. Seriously pretend you're a doctor. E is the only one that makes sense.

Kudos [?]: 1 [0], given: 13

Re: The introduction of new drugs into the market is frequently   [#permalink] 08 Oct 2017, 10:44
Display posts from previous: Sort by

The introduction of new drugs into the market is frequently

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  


GMAT Club MBA Forum Home| About| Terms and Conditions| GMAT Club Rules| Contact| Sitemap

Powered by phpBB © phpBB Group | Emoji artwork provided by EmojiOne

Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.